Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by University Health Network, Toronto.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Merck Frosst Canada Ltd.
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00152932
First received: September 8, 2005
Last updated: July 23, 2007
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given